Phase4 Pharmaceutical LLC Hallandale, FL - 33009

Phase4 Pharmaceutical LLC is categorized under Medical Centers in Hallandale, FL and active since 2012.

Phase4 Pharmaceutical LLC was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 621112 by the NAICS.

If you are seeking more information, feel free to contact Stephen Lapidus at the company’s single location by writing to 212 Three Islands Boulevard # 106, Hallandale, Florida FL 33009 or by phoning (305) 788-6604. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Phase4 Pharmaceutical LLC
Contact Person: Stephen Lapidus
Address: 212 Three Islands Boulevard # 106, Hallandale, Florida 33009
Phone Number: (305) 788-6604
Website Address: ageforce.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Medical Centers
SIC Code: 8011
NAICS Code: 621112
Share This Business:

Phase4 Pharmaceutical LLC was started in 2012 to provide professional Medical Centers under the SIC code 8011 and NAICS code 621112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Stephen Lapidus for inquiries that concern Phase4 Pharmaceutical LLC by calling the company number (305) 788-6604, as your correspondence is most welcome. Additionally, the physical location of the single location of Phase4 Pharmaceutical LLC can be found at the coordinates 25.9888,-80.125606 as well as the street address 212 Three Islands Boulevard # 106 in Hallandale, Florida 33009.

For its online presence, you may visit Phase4 Pharmaceutical LLC’s website at ageforce.com and engage with its social media outlets through on Twitter and on Facebook.